Part of BridgeBio Pharma, Inc., CoA Therapeutics, Inc. is an American company located in San Francisco, CA, that develops biopharmaceuticals.

Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA.

ArmaGen, Inc. engages in operation of a clinical stage biotechnology company focused on developing revolutionary therapies for severe neurological disorders. Its products include AGT-110-Brain-penetrating biologic tumor necrosis factor inhibitor (TNFI) for Alzheimer's disease, AGT-115-Brain-penetrating erythropoietin (EPO) for stroke, AGT-160-Brain penetrating anti-amyloid antibody (AAA) for Alzheimer's disease and AGT-181-Brain-penetrating iduronidase (IDUA) for Mucopolysaccharidosis (MPS) Type I (Hurler's syndrome). The company was founded by William M. Pardridge and Ruben J. Boado in 2003 and is headquartered in San Diego, CA.

CarrierGene Biotech Co., Ltd. engages in the identification of the causes of infertility for patients through genetic testing technology and data analysis algorithms. The company was founded in 2016 and is headquartered in Suzhou, China.

Sapreme Technologies BV operates as a biotech company that develops a platform technology to enable cytosolic delivery of macromolecule therapeutics. The company was founded by Ruben Postel in 2016 and is headquartered in Utrecht, the Netherlands.

The Academic Medical Center (Dutch: Academisch Medisch Centrum), or AMC, is the university hospital affiliated with the Universiteit van Amsterdam (University of Amsterdam). It is one of the largest and leading hospitals of The Netherlands, located in the Bijlmer neighborhood in the most south-eastern part of the city. AMC consistently ranks among the top 50 medical schools in the world.

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises three approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme® (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany.

Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. Its lead product candidate, MRT5005 is designed for the treatment of cystic fibrosis. The company was founded by Arthur M. Krieg and Jeannie T. Lee in 2011 and is headquartered in Lexington, MA.

The Max Planck Society for the Advancement of Science (German: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V.; abbreviated MPG) is a non-governmental and non-profit association of Research Institutes publicly funded by the federal and the state governments of Germany. Additionally, the Max Planck Society and its Institutes receive third party funding from public and private contributions and from the European Union. The world leading organization is named in honor of its former president, theoretical physicist Max Planck. The 86 Institutes and Research Facilities of the Max Planck Society (as of 2020) conduct basic research in the natural sciences, life sciences, social sciences, and the arts and humanities. They have a total staff of approximately 24,000 permanent employees, including 15,000 scientists, and around 5,000 non-tenured scientists and guests. As of December 31, 2018, the proportion of female employees was 44.4 percent. The Max Planck Society (with its 86 Max Planck Institutes) has a world-leading reputation as a science and technology research organization, with more than 33 Nobel Prizes awarded to its scientists, and is widely regarded as one of the foremost basic research organizations in the world.

Guangzhou Yuanguji Technology Co., Ltd., established on 2019-05-20, Business scope includes medical technology transfer services;Medical Technology Consulting,communication service;Internet commodity retail(Except for licensed and approved products);computer hardware research,to develop;E-commerce information consultation;Data Processing and Storage Services;Technical Services(Does not include license approval items);translation service;Information system integration service;Computer Network System Engineering Services;Research on Network Technology,to develop;Information Technology Consulting Services;Conference and Exhibition Services;Biotechnology Consulting,communication service;Network information technology promotion service;Medical technology promotion service;Medical technology research and development;Electronics retail;Commodity wholesale trade(Except for licensed and approved products);Commodity retail trade(Except for licensed and approved products);Gene drug development;Biomedical Technology Research;Wholesale of computer spare parts;Medical Equipment Repair;for medical devices,equipment,Professional cleaning of medical and sanitary materials and supplies,Disinfection and Sterilization;Operation of non-licensed medical devices;Medical supplies and equipment retail(Does not contain drugs and medical devices);Medical equipment rental service;Counseling Services(Does not include medical counseling,Medical Psychological Training,Medical psychological counseling and other medical behaviors);the medical,Medical Consulting Services(Does not involve a medical diagnosis,Treatment and Rehabilitation Services);medical diagnosis,Monitoring and treatment equipment wholesale;Licensed medical device business;medical diagnosis,Monitoring and treatment equipment retail

Fuzhou Aidikang Medical Laboratory Co., Ltd., established on 2009-02-06, Business scope includes licensed projects:medical service;Import and export;Technology Import and Export;road freight transport(Does not contain dangerous goods)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Sales of Class I Medical Devices;software development;software sales;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Information system integration service;Wholesale of computer software, hardware and auxiliary equipment;Retailing of computer software, hardware and auxiliary equipment;Socioeconomic Advisory Services(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

McNeil Nutritionals LLC markets nutritional and health aid products. It provides sweeteners, calcium chews, milk, dietary supplements, spreads and softgels. The company was founded by Alan Kligerman and is headquartered in Fort Washington, PA.

KemPharm Denmark A/S, a subsidiary of KemPharm, Inc., is a Danish company located in Copenhagen that engages in development of novel treatments for central nervous system. It was founded in 2022. Raymond la Duane Clifton is currently the CEO of the firm.

Novozymes is a world leader in bioinnovation. Novozymes works with its partners to innovate new solutions and rethink industries around the world. Novozymes' industrial enzymes, microorganisms, biopolymers, and other proteins allow its customers to achieve more efficient use of raw materials, reduce energy consumption, replace traditional chemicals with more sustainable alternatives, and offer higher-quality products. Novozymes rethinks everyday products every day.

Red Bull GmbH engages in the development and production of energy drinks. Its product portfolio includes Red Bull Energy Drink, Red Bull Sugarfree, Red Bull Zero Calories, Red Bull White Edition, Red Bull Blue Edition, Red Bull Lime Edition, Red Bull Green Edition, Red Bull Yellow Edition, and Red Bull Summer Edition. The firm also sponsors and produces sports events like surfing, motor sports, hockey, football, sailing, and Esports. The company was founded by Dietrich Mateschitz in 1984 and is headquartered in Fuschl am See, Austria.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

ZymoGenetics is focused on the discovery, development, and early manufacture of therapeutic proteins. ZymoGenetics is a fully-integrated research and development organization with a broad range of skills and technologies, including scientific computing, molecular and cellular biology, protein chemistry, antibody generation and engineering, clinical development and operations, regulatory affairs, quality, drug formulation, process development and protein manufacturing.

Henan Julong Biological Engineering Co., Ltd. is a Chinese private company located in Ruzhou. The firm engages in producing and exporting corn starch and amino acid.